Cas:944450-98-0 3-amino-3-(1,3-benzodioxol-5-yl)-2,2-dimethylpropanoic acid,hydrochloride manufacturer & supplier

We serve Chemical Name:3-amino-3-(1,3-benzodioxol-5-yl)-2,2-dimethylpropanoic acid,hydrochloride CAS:944450-98-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

3-amino-3-(1,3-benzodioxol-5-yl)-2,2-dimethylpropanoic acid,hydrochloride

Chemical Name:3-amino-3-(1,3-benzodioxol-5-yl)-2,2-dimethylpropanoic acid,hydrochloride
CAS.NO:944450-98-0
Synonyms:3-amino-3-(2H-1,3-benzodioxol-5-yl)-2,2-dimethylpropanoic acid hydrochloride;3-amino-3-(1,3-benzodioxol-5-yl)-2,2-dimethylpropionic acid hydrochloride
Molecular Formula:C12H16ClNO4
Molecular Weight:273.71300
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:81.78000
Exact Mass:273.07700
LogP:3.02820

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 3-amino-3-(2H-1,3-benzodioxol-5-yl)-2,2-dimethylpropanoic acid hydrochloride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-amino-3-(1,3-benzodioxol-5-yl)-2,2-dimethylpropionic acid hydrochloride physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-amino-3-(1,3-benzodioxol-5-yl)-2,2-dimethylpropionic acid hydrochloride Use and application,3-amino-3-(2H-1,3-benzodioxol-5-yl)-2,2-dimethylpropanoic acid hydrochloride technical grade,usp/ep/jp grade.


Related News: In Massachusetts, where the bulk of Takeda’s U.S. operations are based since the Shire buyout, the Japanese pharma has been swiftly ramping up its cell therapy ambitions. In September, the company cut the ribbon on a new 24,000-square-foot R&D manufacturing center in Boston, which it said at the time would handle clinical development for three ongoing pipeline programs and two other prospects pegged to enter clinical development by the end of 2021. 2-methyl-5-oxo-[1,3]thiazolo[3,2-a]pyrimidine-6-carboxylic acid manufacturers GBS is a rare but potentially life-threatening disorder in which the body’s immune system attacks nerve cells. The condition has been associated with the use of other widely used vaccines, such as GlaxoSmithKline’s Shingrix. 5-amino-4-(2,6-dichlorophenyl)-2-methyl-1H-pyrazol-3-one suppliers The Company most recently announced plans to establish a dedicated laboratory space with Biosafety Level-3 (BSL-3) containment to handle testing of SARS-CoV-2 (the viral strain causing COVID-19) and other similar pathogens that cause human disease. 5-(2-chlorophenyl)-2-methyl-4H-pyrazol-3-one vendor & factory Biogen’s top research chief, Dr. Al Sandrock, defended the drug in an open letter released alongside the company’s earnings Thursday, saying its approval has been subject to “extensive misinformation and misunderstanding.”,The Company most recently announced plans to establish a dedicated laboratory space with Biosafety Level-3 (BSL-3) containment to handle testing of SARS-CoV-2 (the viral strain causing COVID-19) and other similar pathogens that cause human disease.